Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4750599
Max Phase: Preclinical
Molecular Formula: C15H12F3NO3S2
Molecular Weight: 375.39
Molecule Type: Unknown
Associated Items:
ID: ALA4750599
Max Phase: Preclinical
Molecular Formula: C15H12F3NO3S2
Molecular Weight: 375.39
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1sc(NC(=O)c2ccc(SC(F)(F)F)cc2)c(C(=O)O)c1C
Standard InChI: InChI=1S/C15H12F3NO3S2/c1-7-8(2)23-13(11(7)14(21)22)19-12(20)9-3-5-10(6-4-9)24-15(16,17)18/h3-6H,1-2H3,(H,19,20)(H,21,22)
Standard InChI Key: JJADZNPAUOBCIW-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 375.39 | Molecular Weight (Monoisotopic): 375.0211 | AlogP: 4.93 | #Rotatable Bonds: 4 |
Polar Surface Area: 66.40 | Molecular Species: ACID | HBA: 4 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 3.55 | CX Basic pKa: | CX LogP: 6.45 | CX LogD: 3.09 |
Aromatic Rings: 2 | Heavy Atoms: 24 | QED Weighted: 0.74 | Np Likeness Score: -1.69 |
1. Iwaki Y,Yashiro K,Kokubo M,Mori T,Wieting JM,McGowan KM,Bridges TM,Engers DW,Denton JS,Kurata H,Lindsley CW. (2019) Towards a TREK-1/2 (TWIK-Related K+ Channel 1 and 2) dual activator tool compound: Multi-dimensional optimization of BL-1249., 29 (13.0): [PMID:31072652] [10.1016/j.bmcl.2019.04.048] |
Source(1):